NSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹851.50
- Market cap
- ₹82,877 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 56.9×Sector 51.1×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Annual General Meeting
Max Healthcare shareholders approved special resolutions by postal ballot on 19-Oct-2026. These cover a PRSU scheme for up to 73.5 lakh shares, remuneration for the Chairman and MD, and an alteration of the MoA objects clause.
Max Healthcare Institute Board Meeting Date
Max Healthcare's board meets on 30-Oct-2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Max Healthcare Institute Annual General Meeting
Max Healthcare Institute announced the postal ballot voting results. Shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 and other special resolutions.
Max Healthcare Institute Other Announcement
Max Healthcare Institute Limited received an independent ESG rating of '66' from NSE Sustainability Ratings and Analytics. The rating for FY 2025-26 was assigned based on public disclosures.
Max Healthcare Institute Credit Rating
Max Healthcare's CARE AA+ (Stable) long-term and A1+ short-term credit ratings on bank facilities are reaffirmed. No change in rating outlook or amounts.
Max Healthcare Institute Other Announcement
Max Healthcare Institute Limited filed a Regulation 74(5) certificate confirming no dematerialization requests were received during the quarter ended September 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date